-
Antibiotic Recalled Over "Super Potent" Dosage—Serious Side Effects Possible, FDA Warns
28 Mar 2024 16:38 GMT
… to prescription drugs including antibiotics only when doctors deem … Pharmaceuticals, LLC, was pulling four lots of its Vancomycin … is administered orally for treatment of enterocolitis caused by … who currently have the medicine should carefully inspect their …
-
Amneal Pharmaceuticals, LLC. Issues a Nationwide Voluntary Recall of Vancomycin Hydrochloride for Oral Solution USP, 250mg/5mL, Due to the Potential for Some Bottles to be Super Potent Which May be Harmful
28 Mar 2024 01:03 GMT
… 2024
FDA Publish Date:
March 27, 2024
Product Type:
Drugs
Reason …
Amneal Pharmaceuticals, LLC.
Brand Name:
Product Description:
Product Description
Vancomycin Hydrochloride … , is administered orally for treatment of enterocolitis caused by Staphylococcus …
-
Nurse, 7 others arrested in connection to drug trafficking investigation
28 Mar 2024 00:33 GMT
… stolen items included boxes of medical supplies, fentanyl patches, several bottles … manufacture methamphetamine, methamphetamine, drug paraphernalia, synthetic marijuana, liquid morphine, vancomycin, ceftriaxone, xylocaine …
-
Amneal Pharmaceuticals, LLC. Issues a Nationwide Voluntary Recall of Vancomycin Hydrochloride for Oral Solution USP, 250mg/5mL, Due to the Potential for Some Bottles to be Super Potent Which May be Harmful
28 Mar 2024 00:00 GMT
… 2024
FDA Publish Date:
March 27, 2024
Product Type:
Drugs
Reason …
Amneal Pharmaceuticals, LLC.
Brand Name:
Product Description:
Product Description
Vancomycin Hydrochloride … , is administered orally for treatment of enterocolitis caused by Staphylococcus …
-
Amneal Pharmaceuticals, LLC. Issues a Nationwide Voluntary Recall of Vancomycin Hydrochloride for Oral Solution USP, 250mg/5mL, Due to the Potential for Some Bottles to be Super Potent Which May be Harmful
27 Mar 2024 23:28 GMT
… 2024
FDA Publish Date:
March 27, 2024
Product Type:
Drugs
Reason …
Amneal Pharmaceuticals, LLC.
Brand Name:
Product Description:
Product Description
Vancomycin Hydrochloride … , is administered orally for treatment of enterocolitis caused by Staphylococcus …
-
Amneal Pharmaceuticals, LLC. Issues a Nationwide Voluntary Recall of Vancomycin Hydrochloride for Oral Solution USP, 250mg/5mL, Due to the Potential for Some Bottles to be Super Potent Which May be Harmful
27 Mar 2024 23:32 GMT
… 2024
FDA Publish Date:
March 27, 2024
Product Type:
Drugs
Reason …
Amneal Pharmaceuticals, LLC.
Brand Name:
Product Description:
Product Description
Vancomycin Hydrochloride … , is administered orally for treatment of enterocolitis caused by Staphylococcus …
-
DCSO: Search warrant leads to discovery of meth labs, drug thefts; 8 arrested
27 Mar 2024 00:23 GMT
… types of drugs, and the theft of prescription medicine, according … stolen items included boxes of medical supplies, fentanyl patches, … etc.), methamphetamine, drug paraphernalia, synthetic marijuana, liquid morphine, vancomycin, ceftriaxone, xylocaine, …
-
Food Allergy Treatment Drug Market to Register Immense Growth by 2032, Assesses DelveInsight | Key Companies - Vedanta Biosciences, Novartis, Alladapt Immunotherapeutics, Regeneron Pharmaceuticals, Genentech, Parexel
26 Mar 2024 17:00 GMT
… food allergy treatment include Vancomycin plus … Pharmaceuticals, is conducting a multi-center, randomized, double-blind, placebo-controlled trial … clinical trials, visit @ Food Allergy Treatment Drugs … , Genentech, ASIT biotech, BlueWillow Biologics, …
-
What Is a Better Treatment Approach for Immunocompromised Hosts With Clostridioides difficile Infection?
22 Mar 2024 19:14 GMT
… trial data involve the use of vancomycin.3 Additionally, randomized controlled trials … of fidaxomicin versus oral vancomycin for treatment of Clostridium difficile infections … fidaxomicin versus oral vancomycin for the treatment of Clostridium difficile …
-
AGA Clinical Guidelines on the Management of Pouchitis and Inflammatory Pouch Disorders
28 Mar 2024 05:50 GMT
… standardized definitions for the treatment of inflammatory pouch … combination. Additional agents included vancomycin, which was shown … the recently published EARNEST trial, featuring 102 patients … major issues in clinical trials and studies, including …